Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Breast”

16,827 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 16,827 results

Testing effectiveness (Phase 2)Study completedNCT06513364
What this trial is testing

Neoadjuvant Chemotherapy With WH002 in Women With HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Beijing Wehand-Bio Pharmaceutical Co., Ltd 40
Testing effectiveness (Phase 2)UnknownNCT03684863
What this trial is testing

Capecitabine in HER-2 Positive Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Who this might be right for
HER2-positive Breast Cancer
Shandong Cancer Hospital and Institute 200
Not applicableLooking for participantsNCT01900821
What this trial is testing

National Mammography Database

Who this might be right for
Breast Cancer Screening and Diagnosis
American College of Radiology 8,000,000
Testing effectiveness (Phase 2)Study completedNCT00149214
What this trial is testing

Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens

Who this might be right for
Breast Cancer
Eli Lilly and Company 257
Not applicableLooking for participantsNCT04019678
What this trial is testing

Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.

Who this might be right for
Breast Cancer
Istituto Clinico Humanitas 850
Testing effectiveness (Phase 2)UnknownNCT02617043
What this trial is testing

Hypofractionated Whole-breast Irradiation With Simultaneously Integrated Boost For Early-Stage Breast Cancer After Breast-conserving Surgery

Who this might be right for
Breast Cancer
Fudan University 200
Large-scale testing (Phase 3)WithdrawnNCT02539615
What this trial is testing

A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old

Who this might be right for
Breast Cancer, Preneoplastic Conditions, BRCA
Atossa Therapeutics, Inc.
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Not applicableStudy completedNCT04274504
What this trial is testing

Osteopontin in Metastatic Breast Cancer Patients

Who this might be right for
Survival, Prosthesis
Mansoura University 119
Early research (Phase 1)Study completedNCT04993040
What this trial is testing

A PK Study of Oraxol in Breast Cancer Patients

Who this might be right for
Breastcancer
Athenex, Inc. 24
Not applicableActive Not RecruitingNCT03585621
What this trial is testing

Stereotactic Body Radiation Therapy for Breast Cancer

Who this might be right for
Breast Cancer
Toronto Sunnybrook Regional Cancer Centre 24
Not applicableLooking for participantsNCT05317221
What this trial is testing

Developing Breast (Cancer) Organoids

Who this might be right for
Breast Cancer
Maastricht Radiation Oncology 60
Testing effectiveness (Phase 2)Study completedNCT03282214
What this trial is testing

A Self-Management Energy Conservation Program for Cancer-Related Fatigue

Who this might be right for
Cancer-related Problem/ConditionCancer, BreastFatigue
University of Michigan 18
Testing effectiveness (Phase 2)WithdrawnNCT03203616
What this trial is testing

Kadcyla In pAtients With bRAin Metastasis

Who this might be right for
Metastatic HER2-positive Breast Cancer With Brain Metastasis
Jules Bordet Institute
Not applicableActive Not RecruitingNCT05009849
What this trial is testing

Role of Exercise in Breast Cancer Patient Undergoing Treatment

Who this might be right for
Breast Cancer Patients
Tata Memorial Centre 850
Testing effectiveness (Phase 2)Study completedNCT00301548
What this trial is testing

Perioperative Chemotherapy After Primary Chemotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsCarcinoma
European Institute of Oncology 172
Testing effectiveness (Phase 2)Study completedNCT03328026
What this trial is testing

Combination Study of SV-BR-1-GM With Retifanlimab

Who this might be right for
Breast CancerBreast NeoplasmMetastatic Breast Cancer+1 more
BriaCell Therapeutics Corporation 36
Not applicableStudy completedNCT05574478
What this trial is testing

Metastatic Breast Cancer-Specific Prognostic Tool

Who this might be right for
Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center 19
Testing effectiveness (Phase 2)Ended earlyNCT06595563
What this trial is testing

HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerHER2-positive Advanced Breast Cancer
Jules Bordet Institute 87
Large-scale testing (Phase 3)UnknownNCT01019616
What this trial is testing

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Who this might be right for
Primary Breast Cancer
Tao OUYANG 400
Next Page